Impact of biological therapy on work outcomes in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS) and meta-analysis

0
0 / 5 (0 votos)

Annals of the Rheumatic Diseases

Fecha de publicación: 03 august 2018

DOI: http://dx.doi.org/10.1136/annrheumdis-2018-213590

Autores: Joanna Shim, Gareth T Jones, Ejaz M I Pathan, Gary J Macfarlane

Background: To quantify, among patients with axial spondyloarthritis (axSpA), the benefit on work outcomes associated with commencing biologic therapy.

Seguir leyendo